Literature DB >> 18683799

[The effects of cyclosporine A on immunoglobulins deposition in retina of streptozotocin-induced diabetic rats].

Xin Zhang1, Jin Cui, Ming-cai Qiu, De-qiang Li, Peng Zhang, Jin-shi Zhang.   

Abstract

OBJECTIVE: To study the autoimmune injuries on diabetic retinopathy (DR) and the protective effects of immunosuppressive therapy with cyclosporine A (CsA) on the DR of streptozotocin (STZ)-induced diabetic rats.
METHODS: STZ-induced diabetic rats were randomly divided into 3 groups: group 1: diabetic group without any treatment; group 2: insulin-treated group; group 3: CsA-treated group which was further divided into 2 subgroups: subgroup A: CsA was given 1 week before hyperglycemia appeared and subgroup B: CsA was given one week after hyperglycemia appeared. Subgroup A and subgroup B were further subdivided into 3 groups respectively, based on the dose of CsA (1, 4 and 8 mg x kg(-1) x d(-1)). As a control group, normal rats were also simultaneously monitored. The pathologic changes in the retina were investigated with HE stain and the deposition of immunoglobulins was detected with immunohistochemistry and immunofluorescent microscopy.
RESULTS: After 8 week, the deposition of IgG, IgA and IgM was quite significant in the retina of diabetic rats. The data also suggested that insulin treatment had no effects on the DR. In contrast,with CsA intervention, the deposition of immunoglobulins on the retina of diabetic rats vanished.
CONCLUSIONS: Autoimmune injuries were shown, in the present study, to play a critical role in the pathogenesis of diabetic retinopathy. Immunosuppressive treatment with CsA showed protective effects by inhibiting the deposition of immunoglobulins in the retina of diabetic rats.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18683799

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  6 in total

1.  Protective effects of pioglitazone against immunoglobulin deposition on heart of streptozotocin-induced diabetic rats.

Authors:  M Yuan; M Qiu; J Cui; X Zhang; P Zhang
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

Review 2.  Possible roles of anti-type II collagen antibody and innate immunity in the development and progression of diabetic retinopathy.

Authors:  Tsunehiko Ikeda; Kimitoshi Nakamura; Teruyo Kida; Hidehiro Oku
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-11       Impact factor: 3.535

3.  Immunomodulatory and Antidiabetic Effects of a New Herbal Preparation (HemoHIM) on Streptozotocin-Induced Diabetic Mice.

Authors:  Jong-Jin Kim; Jina Choi; Mi-Kyung Lee; Kyung-Yun Kang; Man-Jeong Paik; Sung-Kee Jo; Uhee Jung; Hae-Ran Park; Sung-Tae Yee
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-18       Impact factor: 2.629

4.  Measurement of serum and vitreous concentrations of anti-type II collagen antibody in diabetic retinopathy.

Authors:  Atsuko Nakaizumi; Masanori Fukumoto; Teruyo Kida; Hiroyuki Suzuki; Seita Morishita; Takaki Satou; Hidehiro Oku; Tsunehiko Ikeda; Kimitoshi Nakamura
Journal:  Clin Ophthalmol       Date:  2015-03-20

5.  Cyclosporine-a attenuates retinal inflammation by inhibiting HMGB-1 formation in rats with type 2 diabetes mellitus.

Authors:  Peng Wang; Fei Chen; Xuedong Zhang
Journal:  BMC Pharmacol Toxicol       Date:  2020-02-04       Impact factor: 2.483

Review 6.  The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.

Authors:  Cecilia Beatrice Chighizola; Voon H Ong; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 10.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.